Join
Live feed
·
INSIDERFilingvia Quantisnow
Finch Therapeutics Group Inc. logo

Smisek Jeffery A sold $5,351 worth of shares (1,470 units at $3.64), decreasing direct ownership by 18% to 6,642 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FNCH· Finch Therapeutics Group Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FNCH (Finch Therapeutics Group Inc.) and more on Quantisnow.